{"podcast":{"title":"The BioHub - by Avetix","slug":"the-biohub-by-avetix-7252289","podcast_index_feed_id":7252289,"rss_url":"https://anchor.fm/s/f0076084/podcast/rss","website_url":"https://podcasters.spotify.com/pod/show/max-brennan4","image_url":"https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_nologo/40170153/40170153-1775724702970-e7a36a5e3cf58.jpg","author":"Max Brennan - Biotech HeadHunter","episode_count":230,"summary":"Welcome to The BioHub, where the doors to the world of biotechnology swing wide open. Join your host, Max Brennan, a seasoned biotech recruiter, as he engages in thought-provoking conversations with the brightest minds in biotech. This podcast is your backstage pass to the insights, strategies, and stories that fuel success in the dynamic and ever-evolving biotech landscape. Subscribe now and be part of the conversation that's shaping the future of biotechnology. Get ready for an immersive experience into the world of biotech with The BioHub.","last_synced_at":"2026-07-21T04:19:24.893516+00:00","page_url":"https://stenobird.com/podcast/the-biohub-by-avetix-7252289"},"episode":{"title":"Episode 164 - Natalia Misciattelli - CEO of AAVantgarde","slug":"episode-164-natalia-misciattelli-ceo-of-aavantgarde","published_at":"2026-04-29T08:14:30+00:00","page_url":"https://stenobird.com/podcast/the-biohub-by-avetix-7252289/episode-164-natalia-misciattelli-ceo-of-aavantgarde","show_page_url":"https://stenobird.com/podcast/the-biohub-by-avetix-7252289","url":"https://podcasters.spotify.com/pod/show/max-brennan4/episodes/Episode-164---Natalia-Misciattelli---CEO-of-AAVantgarde-e3iklu2","audio_url":"https://anchor.fm/s/f0076084/podcast/play/119215490/https%3A%2F%2Fd3ctxlq1ktw2nl.cloudfront.net%2Fstaging%2F2026-3-29%2F423101640-44100-2-e7f859e7459b4.mp3","summary":"On this episode we discuss the AAVantgarde story with CEO, Natalia Misciatelli. Founded by Professor Alberto Auricchio in 2021 as a spin-out from Telethon Institute of Genetics and Medicine in Naples, we discuss their dual-vector and intein-based platforms and how the team are positioning to deliver large therapeutic genes for inherited retinal diseases. Backed by household VC names including; Forbion, Atlas Venture, & Sofinnova, Natalia and the team are pursuing game-changing prospects for Stargardt & Usher1b patients. Check this episode out to hear more about their programs, particularly ahead of ARVO where the team will share data from their LUCE ph1/2 study in Usher1b.","meta_description":"On this episode we discuss the AAVantgarde story with CEO, Natalia Misciatelli. Founded by Professor Alberto Auricchio in 2021 as a spin-out from Telethon…","key_points":[],"chapters":[],"topics":[],"duration_seconds":1076,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-biohub-by-avetix-7252289/episodes/episode-164-natalia-misciattelli-ceo-of-aavantgarde/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-biohub-by-avetix-7252289/episode-164-natalia-misciattelli-ceo-of-aavantgarde.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}